We only have this paper's title and publication details.
Read it at the sourceAnalysis reveals superior efficacy of antibody fragment-drug conjugates over IgG-based ADCs, suggesting improved cancer treatment options.
Supplementary Figure 2 showing the synthetic scheme for the linker-payload
No takes yet. Share an insight, caveat, or question.
Stamati et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: